Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04341116 · COMPLETED
Trial details
- NCT number
- NCT04341116
- Sponsor
- I-Mab Biopharma US Limited
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-11
- Primary completion
- 2022-02-07
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.